
2-Dimethylamino-2-oxoethylphosphonic acid diethyl ester | CAS:3842-86-2
2-Dimethylamino-2-oxoethylphosphonic acid diethyl ester
- Name:2-Dimethylamino-2-oxoethylphosphonic acid diethyl ester
- CAS:3842-86-2
- Synonyms:Diethyl 2-(dimethylamino)-2-oxoethylphosphonate; Diethyl N,N-dimethylphosphonoacetamide
- Molecular Formula:C8H18NO4P
- Molecular Weight:223.21
- EINESC:
Description
Properties
Density | 1.1335 g/cm3 (20 ºC)** |
---|---|
Refractive index | 1.4581 (589.3 nm 20 ºC)** |
Safety
没有数据 | 没有数据 |
---|
SDS
Source | SDS/MSDS Samples |
---|---|
没有数据 | 没有数据 |
Synthetic Route
Name | CAS |
---|
More
Articles
Peer-Reviewed Papers
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.Gregory Cairncross et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(3), 337-343 (2012-10-17)
Flow cytometric analysis of Pig-a gene mutation and chromosomal damage induced by procarbazine hydrochloride in CD-1 mice.Souk Phonethepswath et al.Environmental and molecular mutagenesis, 54(4), 294-298 (2013-02-22)
[Escalated BEACOPP as an alternative in high risk Hodgkin lymphoma].Wojciech Jurczak et al.Przeglad lekarski, 69(5), 171-175 (2012-10-12)
Anti-Cancer Drug Design, 143-143 (1994)
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.Martin J van den Bent et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(3), 344-350 (2012-10-17)
Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.Lale Erdem-Eraslan et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(3), 328-336 (2012-12-28)
Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.Wolfgang Dörffel et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(12), 1562-1568 (2013-03-20)
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.Michaela Rancea et al.Journal of the National Cancer Institute, 104(14), NP-NP (2012-07-25)
Prevention and handling of acute allergic and infusion reactions in oncology.M Joerger Annals of oncology : official journal of the European Society for Medical Oncology, 23 Suppl 10, x313-x319 (2012-09-26)
The short-term test activity profile for procarbazine hydrochloride.M D Waters et al.Mutagenesis, 3(2), 89-94 (1988-03-01)
[Necrotizing gastritis in a patient in severe neutropenia].Konrad Pielaciński et al.Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 37(222), 344-347 (2015-02-27)
[Pediatric Hodgkin disease in North Tunisia: clinical and therapeutic study].L Kochbati et al.Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 16(7), 627-632 (2012-10-23)
Improving the prognosis of pediatric Hodgkin lymphoma in developing countries: a Moroccan Society of Pediatric Hematology and Oncology study.Laila Hessissen et al.Pediatric blood & cancer, 60(9), 1464-1469 (2013-04-23)
[Successful treatment for Hodgkin's lymphoma in a female patient with Ph+ chronic myeloid leukemia].N N Sharkunov et al.Terapevticheskii arkhiv, 84(11), 71-74 (2012-12-21)
eIF2alpha phosphorylation is pathognomonic for immunogenic cell deathBezu L, et al. Cell Death and Differentiation, 1-1 (2018)
Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305).Soichiro Shibui et al.Cancer chemotherapy and pharmacology, 71(2), 511-521 (2012-12-12)
Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.Michael Zach Koontz et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(5), 592-598 (2013-01-09)
[Dropped Head Syndrome after whiplash injury in a patient treated for a Hodgkin's lymphoma by mantle field radiotherapy].M Schlienger et al.Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 17(1), 44-49 (2012-12-12)
Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?Kieron Dunleavy et al.Current hematologic malignancy reports, 7(3), 241-247 (2012-07-27)
Eighth Annual Report on Carcinogens, 181-181 (1999)
[Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis].L V Filatova et al.Voprosy onkologii, 59(2), 59-65 (2013-07-03)
[Clinical analysis of childhood and adolescent Hodgkin's lymphoma: a report of 88 cases].Pu-yuan Xing et al.Zhonghua zhong liu za zhi [Chinese journal of oncology], 34(9), 692-697 (2012-11-20)
Nodular sclerosing Hodgkin's disease mimicking Riedel's invasive fibrous thyroiditis.Philippe Oriot et al.Annales d'endocrinologie, 73(5), 492-496 (2012-07-31)
A chemotherapy only therapeutic approach to pediatric Hodgkin lymphoma: AHOPCA LH 1999.E Mauricio Castellanos et al.Pediatric blood & cancer, 61(6), 997-1002 (2013-12-19)
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.Ananth Shankar et al.British journal of haematology, 165(4), 534-544 (2014-04-24)
Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center.Mary R Welch et al.Neuro-oncology, 14(10), 1304-1311 (2012-09-07)
Chemotherapy and radiotherapy combination extends survival for patients with oligodendroglial tumors.Carrie Printz Cancer, 118(18), 4368-4368 (2012-09-07)
Risk-adapted chemotherapy without procarbazine in treatment of children with Hodgkin lymphoma.Yi-Jin Gao et al.World journal of pediatrics : WJP, 9(1), 32-35 (2013-01-01)
[Treatment of advanced Hodgkin lymphoma].S Kreissl et al.Deutsche medizinische Wochenschrift (1946), 138(23), 1212-1214 (2013-05-31)
Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802.Edward G Shaw et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30(25), 3065-3070 (2012-08-02)
Chemotherapy in low-grade gliomas.Aurélien Viaccoz et al.Current opinion in oncology, 24(6), 694-701 (2012-08-24)
Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.Marcus Hentrich et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30(33), 4117-4123 (2012-10-10)
Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.Karolin Behringer et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(2), 231-239 (2012-11-15)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
Name | CAS |
---|

Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!